The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors.EBI
Chonnam National University
Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.EBI
Chonnam National University
Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.EBI
Chonnam National University
Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands.EBI
Chonnam National University
Computer-aided discovery of aminopyridines as novel JAK2 inhibitors.EBI
Chonnam National University
Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.EBI
Chonnam National University
SAR based design of nicotinamides as a novel class of androgen receptor antagonists for prostate cancer.EBI
Chonnam National University
Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors.EBI
Chonnam National University
Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation.EBI
Chonnam National University
Structure-based discovery of pyrazolamides as novel ERRγ inverse agonists.EBI
Chonnam National University
Design, Synthesis, and Biological Activity of l-1'-Homologated Adenosine Derivatives.EBI
Chonnam National University
Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease.EBI
Chonnam National University
SAR study of bisamides as cyclophilin a inhibitors for the development of host-targeting therapy for hepatitis C virus infection.EBI
Chonnam National University
Molecular design, synthesis, and biological evaluation of bisamide derivatives as cyclophilin A inhibitors for HCV treatment.EBI
Chonnam National University
Exploration of substituted arylpiperazine-tetrazoles as promising dual norepinephrine and dopamine reuptake inhibitors.EBI
Chonnam National University
Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.EBI
Chonnam National University
Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands.EBI
Chonnam National University
Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake.EBI
Chonnam National University
Design, synthesis and docking study of 4-arylpiperazine carboxamides as monoamine neurotransmitters reuptake inhibitors.EBI
Chonnam National University
Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazoles.EBI
Chonnam National University